Axq Capital, LP Immunity Bio, Inc. Transaction History
Axq Capital, LP
- $261 Billion
- Q3 2025
A detailed history of Axq Capital, LP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 71,300 shares of IBRX stock, worth $148,304. This represents 0.07% of its overall portfolio holdings.
Number of Shares
71,300
Previous 19,622
263.37%
Holding current value
$148,304
Previous $51.8 Million
238.59%
% of portfolio
0.07%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
299Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...